Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge fund inflows edge slightly higher in 2012 despite end of year redemptions

Friday, January 18, 2013

Bailey McCann, Opalesque New York: Inflows to hedge funds ended 2012 slightly higher than 2011, despite redemptions in December according to new data from eVestment. The industry finished 2012 with assets increasing 5.9% from year end 2011. Credit and macro funds were favored throughout the year over other strategies, seeing the greatest inflows and better returns. Notably, the persistent month to month outflows from emerging markets appears to have abated. Net flows remain negative, but investor sentiment appears to be shifting.

In total, the hedge fund industry ended 2012 with $2.601tn in assets under management, an increase of 0.5%. This number represents the peak for 2012, but is still 13% lower than assets under management in 2008. Investors withdrew an estimated $9.5bn in December resulting in negative net investor flow in Q4 of $10.3bn.

For 2012, investors added $29.2bn to their hedge fund investments versus the $26.5bn added in 2011. The industry had core growth of 1.2% for 2012 - a slight increase over the 1.1% core growth in 2011. These numbers are significantly lower relative to the years immediately following 2008. 2009 and 2010 saw core growth of 5.1% and 3.7% respectively.

Credit surpassed other investment strategies in October 2012 and maintained that advantage through the end of the year - a trend which is continuing in early 2013. According to Peter Laurelli, VP and Head o......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its